newsfilter
← Latest News
GlobeNewswire·

CohBar to Present at H.C. Wainwright 24th Annual Global Investment Conference

MENLO PARK, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ:CWBR), a clinical stage biotechnology company exploiting the power of the mitochondria and the peptides encoded in its genome to develop potential breakthrough therapeutics tar